Hass

Hass EBITDA per Share

The EBITDA per Share of Hass (450330.KQ) as of Nov 22, 2026 is 115.24 KRW. In the previous year, EBITDA per Share was 214.22 KRW — a change of -46.20% (lower).

EBITDA per Share

115.24KRW

YoY

-46.20%

Last updated:

EBITDA per Share of Hass is 2025 115.24 KRW. EBITDA per Share of Hass was 2024 214.22 KRW. It decreases by -46.20% lower compared to the previous year.

The Hass EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
239.08 KRW
Jan 1, 2022
457.01 KRW
Jan 1, 2023
282.79 KRW
Jan 1, 2024
214.22 KRW
Jan 1, 2025
115.24 KRW
The Hass EBITDA per Share history
YEAREBITDA per ShareYoY
115.24KRW-46.20%
214.22KRW-24.25%
282.79KRW-38.12%
457.01KRW+91.16%
239.08KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hass Stock analysis

What does Hass do? Hass Corp is a South Korean company headquartered in Gangneung, Gangwon-Do, operating in the Health Care sector. Listed on 3 July 2024, the company specializes in manufacturing and selling dental medical supplies and pharmaceutical products. It primarily offers dental restorative materials, including lithium disilicate glass-ceramics and zirconia materials, serving the dental industry within South Korea. Hass is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hass stock

EBITDA per Share of Hass is 115.24 KRW in 2025.

EBITDA per Share of Hass changed from 214.22 KRW to 115.24 KRW, representing a -46.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Hass since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hass

All Key Metrics — Hass